Bionomics Ltd.-ADRBNOX
13F holders, Q2 2024 (June 30)13holders +3
3new positions
0sold out
1famous investor
$0.77avg. 13F price*
At the end of Q2 2024, 13 institutions reported holding Bionomics Ltd.-ADR (BNOX) in their 13F filings, up 3 from Q1 2024. 3 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($941K), Lynx1 Capital Management LP ($460K) and Point72 Asset Management ($242K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Bionomics Ltd.-ADR
- CUSIP
- 09063M205
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $969K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 1,298,291 shares bought and 215,494 shares sold, net +1,082,797 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Armistice Capital, LLC | 0.02% | New | 1,226,759 | $941K |
| Lynx1 Capital Management LP | 0.17% | Reduce -26.4% | 599,673 | $460K |
| Point72 Asset Management | 0.00% | No change | 316,000 | $242K |
| UBS Group AG | 0.00% | Add +251.3% | 34,897 | $27K |
| Two Sigma Securities, LLC | 0.00% | New | 26,038 | $20K |
| Lewis Asset Management, LLC | 0.01% | Add +53.3% | 23,000 | $18K |
| Two Sigma Investments, LP | 0.00% | Reduce -4.1% | 16,370 | $13K |
| XTX Topco Ltd | 0.00% | New | 10,940 | $8K |
| Beacon Pointe Advisors, LLC | 0.00% | No change | 10,000 | $8K |
| Rhumbline Advisers | 0.00% | Add +68.2% | 2,195 | $2K |
| Morgan Stanley | 0.00% | Add +744.7% | 794 | $609 |
| Aspire Private Capital, LLC | 0.00% | No change | 200 | $153 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is BNOX's weight in each manager's 13F, not the share of Bionomics Ltd.-ADR the manager owns.